U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07591519) titled 'Clinical Trials of IBI3035 in Healthy Subjects' on April 21.
Brief Summary: This study is a Phase I clinical trial that uses positive glucose clamping technology to evaluate the pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence of IBI3035 with insulin injection (Awiqli?) after a single administration in healthy male subjects
Study Start Date: May 08
Study Type: INTERVENTIONAL
Condition:
Healthy Person
Intervention:
BIOLOGICAL: IBI3035
IBI3035 administered subcutaneously(SC)
BIOLOGICAL: Insulin icodec Injection
Insulin icodec Injection administered subcutaneously(SC)
Recruitment Status: NOT_YET_RECRUITING
Sponsor...